Target Audience
This activity has been designed to meet the educational needs of healthcare providers interested in developing a greater expertise in the area of hepatitis C screening, diagnosis and management.

Statement of Need/Program Overview
The purpose of this activity is to help healthcare providers to properly screen patients for HCV, and link the patients that require follow-up care with the appropriate resources.

Educational Objectives
At the conclusion of this initiative, participants will do the following:
• Describe the epidemiology and natural history of HCV
• Summarize the importance of HCV screening, diagnosis and linkage to specialty care and discuss updates in screening mandates and linkage to care recommendations

Physician Accreditation Statement
This activity has been planned and implemented by the Duke University Health System Department of Clinical Education & Professional Development and the Chronic Liver Disease Foundation for the advancement of patient care. The Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the health care team.

Credit Designation
Duke University Health System Department of Clinical Education & Professional Development designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s). Physicians should claim only credit commensurate with the extent of their participation in the activity.

Estimated time to complete these two online activities: 30 minutes

NOTE: Both webcasts must be viewed in their entirety in order to claim credit.

Cost of activity
There is no charge for this activity.

Faculty Disclosure Statement

Planning Committee/Faculty Disclosure
The following speakers and/or planning committee members have indicated that they have relationship(s) with industry to disclose:

Robert Brown, MD
Columbia University Medical Center

Robert Brown, MD serves as a consultant for Bristol-Myers Squibb, Genentech, Gilead, Johnson & Johnson, Merck, and Vertex. Dr. Brown is a principal investigator for Bristol-Myers Squibb & Genentech.

Andrew Muir, MD
Activity Medical Director
Duke University Medical Center, Durham, North Carolina, USA

Andrew Muir, MD has an advisory board membership with Abbott Pharmaceuticals, Bristol-Myers Squibb, Gilead, Janssen, Merck, and Vertex. He serves as a consultant for GlaxoSmithKline and Lumena. Dr. Muir is a principal investigator for Abbott Pharmaceuticals, Achillion, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Hologic, Janssen, Merck, NGM Pharmaceuticals, Roche, and Vertex.

Rachel Bejarano, PharmD
Rachel Bejarano has no relationships to disclose.

Release: April 06, 2014 Expiration: April 06, 2015


Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit both webcasts must be viewed and you must receive a minimum score of 80% on the post-test.

Follow these steps to earn CME/CE credit:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must complete the Activity Evaluation to provide feedback for future programming.

This activity is supported by educational grants from AbbVie, Bristol-Myers Squibb, Gilead Sciences, and Janssen Therapeutics.


(Click on the links below to view the webcasts)

Jointly provided by the Duke University Health System Department of Clinical Education & Professional Development and The Chronic Liver Disease Foundation.